Cancer BiologybioRxivPreprint
A novel Fc-optimized antibody drug conjugate targeting CD7 for the therapy of T-cell acute lymphoblastic leukemia
Carina Lynn Gehlert, Denis Martin Schewe, Katja Klausz…·Matthias Peipp
This paper evaluates a novel Fc-optimized antibody drug conjugate targeting CD7, showing potent anti-leukemia activity in preclinical T-ALL models.
DOI 10.1101/2025.10.30.684608